Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
44.55
+0.27 (0.61%)
May 20, 2026, 9:41 AM EDT - Market open

Novo Nordisk Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
197,762227,179382,071461,264304,575256,424
Market Cap Growth
-35.92%-40.54%-17.17%51.44%18.78%58.68%
Enterprise Value
217,121241,627390,912459,827304,682255,732
Last Close Price
44.5550.8886.02103.4667.6756.00
PE Ratio
10.5114.0627.2437.5338.4735.31
PS Ratio
3.914.689.4313.4111.9611.91
PB Ratio
6.317.4519.0829.2425.3523.70
P/TBV Ratio
0.981.172.684.363.683.65
P/FCF Ratio
21.0824.5337.1037.4931.7134.46
P/OCF Ratio
10.8212.1422.6428.6126.8230.49
EV/Sales Ratio
4.294.989.6513.3711.9611.88
EV/EBITDA Ratio
8.0910.2819.0027.7325.7625.86
EV/EBIT Ratio
8.7212.0521.8330.2828.3028.52
EV/FCF Ratio
23.1526.0937.9637.3731.7234.36
Debt / Equity Ratio
0.590.610.620.190.290.18
Debt / EBITDA Ratio
0.860.880.700.240.310.41
Debt / FCF Ratio
1.662.221.390.330.390.55
Net Debt / Equity Ratio
0.610.540.53-0.030.030.13
Net Debt / EBITDA Ratio
0.730.700.52-0.030.030.14
Net Debt / FCF Ratio
1.411.761.04-0.040.030.19
Asset Turnover
0.590.610.740.840.810.83
Inventory Turnover
1.181.301.231.271.291.24
Quick Ratio
0.490.480.460.570.620.60
Current Ratio
0.790.800.740.820.890.86
Return on Equity (ROE)
61.42%60.70%80.78%88.07%72.00%71.24%
Return on Assets (ROA)
21.11%19.86%26.12%29.51%27.60%27.93%
Return on Invested Capital (ROIC)
22.83%21.82%29.93%35.60%32.49%32.18%
Return on Capital Employed (ROCE)
44.91%44.38%65.34%77.37%69.49%69.14%
Earnings Yield
9.51%7.11%3.67%2.66%2.60%2.83%
FCF Yield
4.74%4.08%2.70%2.67%3.15%2.90%
Dividend Yield
2.88%3.60%1.61%1.01%1.19%1.28%
Payout Ratio
30.39%50.53%43.71%37.96%45.57%45.06%
Buyback Yield / Dilution
0.20%0.34%0.71%1.10%1.34%1.58%
Total Shareholder Return
3.08%3.94%2.31%2.11%2.53%2.86%
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q